Login to Your Account



ESBATech's Series B Adds $22M for Antibody Fragment Pipeline

By Jennifer Boggs


Wednesday, August 13, 2008
No Abstract

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription